Nuzenio

Allsci Allsci

Allsci Allsci entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 24 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Arcturus and CSL Seqirus terminate sa-mRNA vaccine partnership - AllSciAllSci · Fri, 07 Aug 2026 16:13:37 GMT Shape and Rett Syndrome Research Trust advance AI-designed RNA editor for R168X mutation - AllSciAllSci · Fri, 07 Aug 2026 15:03:13 GMT Tarsus secures USD 125m to fund Alkeus acquisition and expand eye care pipeline - AllSciAllSci · Fri, 07 Aug 2026 14:59:09 GMT Dispatch advances synthetic-antigen CAR T platform into first-in-human testing - AllSciAllSci · Fri, 07 Aug 2026 14:50:34 GMT Vistagen reports exploratory Phase II miss for social anxiety drug candidate - AllSciAllSci · Fri, 07 Aug 2026 14:39:45 GMT Edding Genor tries trispecific PD-1/CTLA-4/VEGF antibody against breast cancer - AllSciAllSci · Fri, 07 Aug 2026 14:00:52 GMT ReCode expands cystic fibrosis gene editing push with new CF Foundation backing and unnamed partner - AllSciAllSci · Fri, 07 Aug 2026 13:54:55 GMT Biogen closes deal for USD 1b buyout of RayThera - AllSciAllSci · Fri, 07 Aug 2026 13:52:15 GMT

Timeline

Fri, 07 Aug 2026 16:13:37 GMTArcturus and CSL Seqirus terminate sa-mRNA vaccine partnership - AllSci

Fri, 07 Aug 2026 15:03:13 GMTShape and Rett Syndrome Research Trust advance AI-designed RNA editor for R168X mutation - AllSci

Fri, 07 Aug 2026 14:59:09 GMTTarsus secures USD 125m to fund Alkeus acquisition and expand eye care pipeline - AllSci

Fri, 07 Aug 2026 14:50:34 GMTDispatch advances synthetic-antigen CAR T platform into first-in-human testing - AllSci

Fri, 07 Aug 2026 14:39:45 GMTVistagen reports exploratory Phase II miss for social anxiety drug candidate - AllSci

Fri, 07 Aug 2026 14:00:52 GMTEdding Genor tries trispecific PD-1/CTLA-4/VEGF antibody against breast cancer - AllSci

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

USD10 live mentions RNA4 live mentions Alkeus4 live mentions CSL Seqirus2 live mentions Rett Syndrome Research2 live mentions Trust2 live mentions Tarsus2 live mentions AllSci Tarsus2 live mentions CAR T2 live mentions Phase II2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Allsci Allsci.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.